Literature DB >> 2007858

Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes.

M R Alderson1, T W Tough, S F Ziegler, K H Grabstein.   

Abstract

Peripheral blood monocytes can be induced by stimuli such as bacterial lipopolysaccharide (LPS) to secrete an array of cytokines. We have studied the effects of interleukin 7 (IL-7) on human peripheral blood mononuclear cells (PBMC) and found that IL-7 is a relatively potent inducer of IL-6 secretion IL-6 protein levels were determined either by the B9 hybridoma growth factor assay or by enzyme-linked immunosorbent assay, and mRNA for IL-6 was analyzed by Northern hybridization. Detailed examination revealed that, among PBMC, monocytes, rather than lymphocytes, were secreting IL-6 in response to IL-7. In contrast to the low concentrations of IL-7 required to stimulate T cell growth and differentiation (as low as 0.1 ng/ml), relatively high concentrations of IL-7 were necessary to induce IL-6 secretion by monocytes (at least 10 ng/ml). An optimal concentration of IL-7 (100 ng/ml) induced monocytes to secrete 10-fold more IL-6 than an optimal concentration of IL-1 beta (10 ng/ml), and almost as much as LPS. However, significantly more IL-7 than IL-1 beta was required to induce detectable levels of IL-6. The kinetics of IL-6 secretion by monocytes were identical in response to IL-7, IL-1 beta, or LPS, with IL-6 protein detectable in culture supernatants as early as 2 h after the initiation of culture. IL-4 was found to markedly inhibit the ability of IL-7 or LPS to induce IL-6 mRNA and IL-6 secretion. In addition to promoting IL-6 production, IL-7 induced the secretion of immunoreactive IL-1 alpha, IL-1 beta, and tumor necrosis factor alpha (TNF-alpha) by monocytes. IL-7 also induced monocyte/macrophage tumoricidal activity against a human melanoma cell target, an activity that may be related to the secretion of IL-1 alpha, IL-1 beta, and TNF-alpha. Finally, we used a whole blood culture system as a bridge to in vivo analysis to demonstrate that IL-7 induces cytokine secretion in the absence of culture medium, fetal calf serum, and adherence to plastic. Our data suggest that IL-7, in addition to regulating lymphocyte growth and differentiation, has potent effects on cells of the monocytic lineage. Thus, IL-7 may be an important mediator in inflammation and in the macrophage immune response to tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007858      PMCID: PMC2190815          DOI: 10.1084/jem.173.4.923

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Detection by in situ hybridization and phenotypic characterization of cells expressing IL-6 mRNA in human stimulated blood.

Authors:  K Kato; T Yokoi; N Takano; H Kanegane; A Yachie; T Miyawaki; N Taniguchi
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

2.  Regulation of human T cell proliferation by IL-7.

Authors:  R J Armitage; A E Namen; H M Sassenfeld; K H Grabstein
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

3.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

4.  Interleukin 7 is a T-cell growth factor.

Authors:  G D Chazen; G M Pereira; G LeGros; S Gillis; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

Authors:  P H Hart; G F Vitti; D R Burgess; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

Authors:  Y Ueno; N Takano; H Kanegane; T Yokoi; A Yachie; T Miyawaki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells.

Authors:  Y Horii; A Muraguchi; S Suematsu; T Matsuda; K Yoshizaki; T Hirano; T Kishimoto
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

8.  Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.

Authors:  M H Van Oers; A A Van der Heyden; L A Aarden
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

9.  B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors.

Authors:  A E Namen; A E Schmierer; C J March; R W Overell; L S Park; D L Urdal; D Y Mochizuki
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells.

Authors:  P J Morrissey; R G Goodwin; R P Nordan; D Anderson; K H Grabstein; D Cosman; J Sims; S Lupton; B Acres; S G Reed
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  48 in total

1.  The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7.

Authors:  M Watanabe; N Watanabe; Y Iwao; H Ogata; T Kanai; Y Ueno; M Tsuchiya; H Ishii; S Aiso; S Habu; T Hibi
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Organization of the murine and human interleukin-7 receptor genes: two mRNAs generated by differential splicing and presence of a type I-interferon-inducible promoter.

Authors:  C M Pleiman; S D Gimpel; L S Park; H Harada; T Taniguchi; S F Ziegler
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

3.  Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.

Authors:  T Aoki; K Tashiro; S Miyatake; T Kinashi; T Nakano; Y Oda; H Kikuchi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Comparative model building of interleukin-7 using interleukin-4 as a template: a structural hypothesis that displays atypical surface chemistry in helix D important for receptor activation.

Authors:  L Cosenza; A Rosenbach; J V White; J R Murphy; T Smith
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

5.  Tributyltin exposure alters cytokine levels in mouse serum.

Authors:  Shanieek Lawrence; Samuel T Pellom; Anil Shanker; Margaret M Whalen
Journal:  J Immunotoxicol       Date:  2016-09-07       Impact factor: 3.000

6.  Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain-Barré syndrome: decreased concentrations in the early course and increase with motor function.

Authors:  A Créange; L Bélec; B Clair; J D Degos; J C Raphaël; R K Gherardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

7.  Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.

Authors:  A Gessner; A Will; M Vieth; K Schröppel; M Röllinghoff
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

8.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice.

Authors:  Miyoung Lee; Su Jin Song; Myung-Sook Choi; Rina Yu; Taesun Park
Journal:  Diabetologia       Date:  2015-07-08       Impact factor: 10.122

10.  Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.

Authors:  T N Liao; K H Hsieh
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.